AIGEA Medical is a Medtech startup, focusing on Artificial Intelligence applied to radiology workflows and digital imaging. DeepMammo is our award-winning cloud solution for early detection of Breast Cancer.

We are a team of global experts and technical visionaries, which has founded AIGEA Medical as an innovative startup. AIGEA Medical management team has more than 50 years of expertise in the MedTech and Radiology market, spanning a mix of IT experts and AI Scientists supported by a Clinical Advisory board accommodating radiologists and clinical experts.


DeepMammo is an Artificial Intelligence for early detection of breasts cancer.

Exploiting proprietary MultiModal Deep Neural Networks, DeepMammo reduces diagnostic errors, supports daily workloads and therefore improves clinical practice while reduces costs.
Finally, by reducing the cancer screening time and envisaging a personalized screening method, Deepmammo simplifies and speeds-up daily screening activities.


DeepMammo is Explainable AI with Multimodal Neural Networks


Impact on Society

Breast screening is performed on the whole range of women population after a certain age, therefore the impact is very wide. Cancer has a strong social impact, over the patient, and consequently on relatives.

What is even more hard to sustain, it is the impact of life habits and working style.
Our project, by reducing errors and diagnoses time, will have a strong social and economic impact on the people, affecting the primary need of healthcare and wellness.

Sustainable Development Goals of United Nations Foundation

DeepMammo has a direct impact on two main SDGs of the UN Agenda for Sustainable Development, strongly related to Societal aspects:


We are open to talented people to join our team

Apply now